AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics, Inc. (“Mirna”) announced today that the United States Patent and Trademark Office has allowed multiple patent claims related to the therapeutic application of several tumor suppressor microRNAs (miRNAs). These and earlier allowances for miR-34 and let-7 stemming from the Company’s broad and early patent filings dating back to 2004 are enabling Mirna to establish a major intellectual property position in the burgeoning field of miRNA-based therapeutics.